Abstract 688: Triphenylstannyl 2-(benzylcarbamoyl)benzoate (Ch-319) modulates AKT/FOXO3a signaling and inhibits progression of prostate cancer
Year: 2018
Type: conference-abstract
Source: Cancer Research
Institutions: University of Wisconsin–Madison, Quaid-i-Azam University
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2885666844
